efficacy of a non-hypercalcemic vitamin-d2 derived anti-cancer agent (mt19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft model功效的non-hypercalcemic维生素d2派生抗癌剂(mt19c)和抑制脂肪酸合成的卵巢癌异种移植模型.pdfVIP

Efficacy of a Non-Hypercalcemic Vitamin-D2 Derived Anti-Cancer Agent (MT19c) and Inhibition of Fatty Acid Synthesis in an Ovarian Cancer Xenograft Model 1 1 1 1 2 1 Richard G. Moore , Thilo S. Lange , Katina Robinson , Kyu K. Kim , Alper Uzun , Timothy C. Horan , 1 3 4 4 5 4 Nada Kawar , Naohiro Yano , Sharon R. Chu , Quanfu Mao , Laurent Brard , Monique E. DePaepe , 2 6 7 8 1 James F. Padbury , Leggy A. Arnold , Alexander Brodsky , Tun-Li Shen , Rakesh K. Singh * 1 Molecular Therapeutics Laboratory, Program in Women’s Oncology, Department of Obstetrics and Gynecology, Women and Infants’ Hospital of Rhode Island, Alpert Medical School, Brown University, Providence, Rhode Island, United States of America, 2 Center for Computational Molecular Biology, Department of Pediatrics, Women and Infants’ Hospital of Rhode Island, Alpert Medical School, Brown University, Providence, Rhode Island, United States of America, 3 Department of Pediatrics, Women and Infants’ Hospital of Rhode Island, Alpert Medical School, Brown University, Providence, Rhode Island, United States of America, 4 Developmental Pathology, Women and Infants’ Hospital of Rhode Island, Alpert Medical School, Brown University, Providence, Rhode Island, United States of America, 5 Gynecology Oncology, Southern Illinois Medical School, Springfield, Illinois, United States of America, 6 Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, United States of America, 7 Department of Biology and Medicine, Brown Un